Literature DB >> 35870083

Male Predisposition in Cerebellar Mutism Syndrome: a Cohort Study.

Wei Yang1, Ming Ge2, Kaiyi Zhu3, Jiashu Chen1, Ping Yang1, Yingjie Cai1, XiaoJiao Peng1, Jia Wang1, Hailang Sun1, Yuanqi Ji1, Fengmao Zhao1, Hong Zhang4.   

Abstract

The aim of this study was to explore the association between sex and cerebellar mutism syndrome and to examine other potential risk factors. This ambispective cohort study examined 218 pediatric patients (132 boys) with a posterior fossa tumor who underwent tumor resection from July 2013 to March 2021. The patients' demographics and tumor characteristics were examined and statistically analyzed to explore the associations among the variables. Multivariable and subgroup analyses were conducted to validate the independent risk factors for cerebellar mutism syndrome (CMS). The male and female patients did not differ significantly in terms of age, tumor size, tumor location, tumor consistency, VP shunt placement before resection, extent of resection, or surgeon, as well as with respect to the presence of hydrocephalus or paraventricular edema. The overall incidence of CMS was 32.6%. The incidence of CMS was significantly higher in male patients than that in female patients (41.7% vs. 18.6%; P = 0.001). In the multivariable analysis, male sex (adjusted odds ratio [OR], 3.27; P = 0.001), solid tumor consistency (adjusted OR, 5.61; P = 0.001), midline location (adjusted OR, 3.78; P = 0.004), and hydrocephalus (adjusted OR, 2.56; P = 0.047) were independent risk factors for the CMS. Chi-square analysis revealed that solid tumor consistency and midline location were associated with medulloblastoma (P < 0.001). Male patients had a higher risk of developing CMS after a posterior fossa tumor resection. Midline location, solid tumor consistency, and hydrocephalus were independent risk factors for CMS.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cerebellar mutism syndrome; Cohort study; Risk factor; Sex bias

Year:  2022        PMID: 35870083     DOI: 10.1007/s12311-022-01449-6

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.648


  3 in total

1.  Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.

Authors:  Patricia L Robertson; Karin M Muraszko; Emiko J Holmes; Richard Sposto; Roger J Packer; Amar Gajjar; Mark S Dias; Jeffrey C Allen
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

Review 2.  Cerebellar Mutism Syndrome after surgical resection of posterior fossa neoplastic lesions.

Authors:  Saqib Kamran Bakhshi; Rida Mitha; Naureen Mushtaq; Muhammad Shahzad Shamim
Journal:  J Pak Med Assoc       Date:  2020-09       Impact factor: 0.781

3.  Molecular correlates of cerebellar mutism syndrome in medulloblastoma.

Authors:  Rashad Jabarkheel; Nisreen Amayiri; Derek Yecies; Yuhao Huang; Sebastian Toescu; Liana Nobre; Donald J Mabbott; Sniya V Sudhakar; Prateek Malik; Suzanne Laughlin; Maisa Swaidan; Maysa Al Hussaini; Awni Musharbash; Geeta Chacko; Leni G Mathew; Paul G Fisher; Darren Hargrave; Ute Bartels; Uri Tabori; Stefan M Pfister; Kristian Aquilina; Michael D Taylor; Gerald A Grant; Eric Bouffet; Kshitij Mankad; Kristen W Yeom; Vijay Ramaswamy
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.